Management & Regulatory

What's New in Biopharma: Spinraza, Supply Struggles, and Leadership Shifts?
Management & Regulatory What's New in Biopharma: Spinraza, Supply Struggles, and Leadership Shifts?

In an industry perpetually teetering on the edge of innovation and regulation, recent events in the biopharmaceutical sector underscore the volatile yet progressive nature of biotech and pharma companies. From advancements in specific treatments to significant executive shifts, the landscape seems

How Is DHL Boosting Boehringer’s Supply Chain Sustainability Goals?
Management & Regulatory How Is DHL Boosting Boehringer’s Supply Chain Sustainability Goals?

In a move that promises to set new standards in supply chain sustainability, DHL Supply Chain has joined forces with biopharmaceutical company Boehringer Ingelheim to transform its warehousing and logistics operations in Australia and New Zealand. The partnership aims to enhance efficiency,

BioPhorum Acquires Brookwood Global to Boost Clinical Research Training
Management & Regulatory BioPhorum Acquires Brookwood Global to Boost Clinical Research Training

In a strategic move to enhance its offerings in the biopharmaceutical sector, BioPhorum has announced the acquisition of Brookwood Global, a renowned UK-based training and educational content provider specializing in clinical research and drug safety. For over 15 years, BioPhorum has been a key

How Will Oruka Therapeutics Transform Chronic Skin Disease Treatment?
Management & Regulatory How Will Oruka Therapeutics Transform Chronic Skin Disease Treatment?

Chronic skin diseases like plaque psoriasis have long posed significant challenges for patients and medical professionals alike, with existing treatments often falling short in efficacy and patient compliance. However, the emergence of Oruka Therapeutics, Inc. is positioned to revolutionize the

Insider Buying Signals Confidence as Analysts Downgrade Theravance
Management & Regulatory Insider Buying Signals Confidence as Analysts Downgrade Theravance

Theravance Biopharma Inc. (NASDAQ: TBPH) has recently garnered significant attention due to a series of notable insider transactions, varied analyst ratings, and fluctuating stock performance. These events offer deep insights into the current state and future trajectory of the company, presenting a

How Will AstraZeneca’s $135M Sweden Plant Expansion Impact Biologics?
Management & Regulatory How Will AstraZeneca’s $135M Sweden Plant Expansion Impact Biologics?

AstraZeneca has set the wheels in motion to significantly expand its biomanufacturing capacities with a $135 million investment in the Sweden Biomanufacturing Center in Södertälje. This venture marks the company's largest single investment in the facility since its inception in 2021, i

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later